Business Context and Reporting Period
Company: James Hardie Industries Plc
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: April 17, 2019
Reporting Period: Month of April 2019
Principal Executive Offices: Dublin 2, Ireland
This filing serves as a report of a change in substantial holding (Exhibit 99.1). It does not contain a full financial report for the period.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding a change in substantial holding and does not include operational or financial performance data for the period.
Material Changes
Change in Substantial Holding: The filing discloses a change in substantial holding as detailed in Exhibit 99.1. The specific details of the change (e.g., percentage, party involved) are contained within the exhibit and are not summarized in the main body of this text.
Guidance, Outlook, and Risks
Forward-Looking Statements: The document contains extensive forward-looking statements regarding future performance, capital expenditures, credit facilities, dividends, and tax liabilities. These are qualified by significant risks and uncertainties.
Key Risk Factors Identified:
- Asbestos Liability: Risks related to prior asbestos manufacturing, including contributions to the Asbestos Injuries Compensation Fund (AICF), potential shortfalls, and currency exchange impacts on liabilities.
- Legal and Regulatory: Exposure to product liability, environmental, and consumer class action proceedings.
- Market Conditions: Dependence on US and Asia Pacific housing markets, new home construction levels, and consumer confidence.
- Operational Risks: Supply and cost of raw materials, competition, and integration of the Fermacell business.
- Financial Risks: Currency exchange risks and the ability to renew credit facilities on favorable terms.
Investor Verification Checklist
- Review Exhibit 99.1 to determine the specific details of the change in substantial holding.
- Consult the most recent Form 20-F or quarterly reports for actual financial performance metrics (revenue, profit, cash flow) as they are absent from this filing.
- Monitor updates regarding the Asbestos Injuries Compensation Fund (AICF) and associated liability estimates.
- Verify the status of the Fermacell integration and its impact on operations.
- Check for any new legal proceedings or regulatory changes affecting the US and Asia Pacific construction markets.